1. Introduction {#sec1-nutrients-10-00555}
===============

Hip fractures represent a significant health risk for older populations because the incidence of fractures increases notably with age \[[@B1-nutrients-10-00555]\].

Hip fractures in geriatric patients have a negative impact on functional status and quality of life, and are associated with high mortality \[[@B2-nutrients-10-00555],[@B3-nutrients-10-00555]\]. Despite the reduction in pre-surgery hospital stay (surgery performed in the first 24 h, or 48 h after admission, is associated with fewer post-operative complications) \[[@B4-nutrients-10-00555]\], and improvements in the management of complications, many patients with hip fracture presented functional deterioration \[[@B5-nutrients-10-00555]\]. Identifying the risk factors that predict functional loss after a hip fracture could reduce the costs associated with the need for help resulting from loss of autonomy \[[@B6-nutrients-10-00555]\] and institutionalization \[[@B7-nutrients-10-00555]\], and could also improve the treatment of post-operative complications. The need for help in order to be able to walk within a patient's home, Parkinson's disease, smoking, having suffered delirium in the previous month, having a Body Mass Index (BMI) \< 22 kg/m^2^, and age are among the independent risk factors for hip fractures \[[@B8-nutrients-10-00555]\]. Poor nutritional status, defined by the Mini Nutritional Assessment (MNA), was associated with a higher risk of fracture at any site \[[@B9-nutrients-10-00555]\]. Among risk factors for hip fracture as well as functional loss after the fracture, malnutrition represents an area of great interest, principally because it is a modifiable risk factor. The identification of malnutrition is widely accepted as an appropriate procedure, which may help to give patients better care \[[@B10-nutrients-10-00555]\]. This review represents an actualization of the evidence previously published on this topic. The novelty of this review is that we included not only studies with nutritional interventions, but also studies that have assessed the nutritional status in older patients with hip fracture.

The principal objective of this review is to describe how both nutritional status, as revealed by malnutrition biomarkers, influences the clinical evolution and mortality of older people with hip fracture, as well as the impact of nutritional intervention. We therefore structured this paper into four chapters concerning subjects with hip fracture: (1) prevalence of malnutrition and nutritional status aspects (including anthropometry, blood biomarkers, and energy intake), (2) influence upon outcomes and complications, (3) mortality, and (4) effects of nutritional intervention.

2. Material and Methods {#sec2-nutrients-10-00555}
=======================

2.1. Data Sources and Search Strategy {#sec2dot1-nutrients-10-00555}
-------------------------------------

A search was carried out on the electronic database MEDLINE for papers published from January 1990 until December 2017. The search strategy is detailed in Supplementary data. The search was restricted to articles in English, Spanish, or Italian. The references of the selected articles were manually revised in the search for eligible articles. Whenever there were studies with multiple publications about the same population, the study with the largest sample was selected, as long as it respected our inclusion criteria.

2.2. Inclusion and Exclusion Criteria {#sec2dot2-nutrients-10-00555}
-------------------------------------

We included observational and cohort studies that evaluated the presence of malnutrition (defined by MNA, BMI, albumin concentration, or weight loss), and the influence of malnutrition, as revealed by nutritional biomarkers, on functional recovery, post-operative complications, and mortality in hip fracture patients. We considered as nutritional biomarkers: (1) anthropometric parameters, such as BMI, mid-arm circumference, and triceps skinfold; (2) blood concentrations of total proteins, albumin, and micronutrients such as vitamin D and calcium. We also included controlled clinical trials with nutritional intervention. We defined an intervention as cases where patients received supplements (either orally, by tube, or intravenously) or advice on the characteristics of the diet (by a specialized nurse or dietician). We consider studies (which included only males, only females, or both sexes) carried out in populations with an average age of 70 years or above. Reviews and protocols that did not provide results were excluded.

2.3. Data Extraction {#sec2dot3-nutrients-10-00555}
--------------------

The title and abstract of papers compiled from the search were evaluated by two researchers who carried out data extraction. Doubts and queries were discussed and whenever these could not be solved, the opinion of a third reviewer was requested. Studies were grouped according to their main objective. When necessary we contacted the corresponding author to request data that did not appear in the paper.

2.4. Quality Assessment {#sec2dot4-nutrients-10-00555}
-----------------------

The quality of the selected studies was determined with both the National Institutes of Health (NIH) Quality Assessment tool for Observational Cohort and Cross-Sectional Studies and the Quality Assessment of Controlled Intervention Studies \[[@B11-nutrients-10-00555]\]. These tools have been designed to evaluate internal validity and bias risk for both types of observational and intervention studies, and each consists of 14 evaluation criteria. The criteria for observational studies are: aims of the study, sources of bias, sampling, participation rate, study power, data collection methods, and confounding. The criteria for intervention studies are: objective of the study, population characteristics, sampling, selection criteria, sample size justification, exposure measured, timeframe, categories of exposure, independent variables, exposure over the time, dependent variables, blinded, drop-out, and confounding. The criteria were rated as either yes, no, or "other" (i.e., CD, cannot determine; NA, not applicable; NR, not reported). The overall assessment of the studies were classified as "good", "fair", or "poor".

3. Results {#sec3-nutrients-10-00555}
==========

This review included 44 papers, which totaled 26,281 subjects with a mean age 83.6 ± 7.2 years. The population was mostly female (73.5%). The overall quality of the included studies was rated as fair ([Supplementary Tables S1 and S2](#app1-nutrients-10-00555){ref-type="app"}).

3.1. Prevalence of Malnutrition and Nutritional Status Aspects in Hip Fracture Patients {#sec3dot1-nutrients-10-00555}
---------------------------------------------------------------------------------------

In all of the studies included, malnutrition was identified by a validated nutritional assessment tool. Nevertheless, the prevalence of malnutrition changed according to diagnostic tool used. The prevalence of malnutrition was 18.7% using the MNA (long or short form), but it was greater if other diagnostic criteria were used (BMI, albumin, or weight loss) (45.7%). The prevalence of malnutrition, of risk of malnutrition, and the diagnostic tool used in each study are presented in [Table 1](#nutrients-10-00555-t001){ref-type="table"}.

In this section we included 10 studies that assessed the nutritional status of older people with hip fracture, with a total of 1575 subjects (88.3% female, mean age 79.6 ± 4 years). The design of the studies, the general characteristics of the populations studied, and the main results are presented in [Table 2](#nutrients-10-00555-t002){ref-type="table"}.

Patients with hip fracture present malnutrition, as demonstrated by the presence of low values of the anthropometric indices. Several studies showed that energy intake in older people is smaller than that required and recommended \[[@B12-nutrients-10-00555],[@B13-nutrients-10-00555],[@B14-nutrients-10-00555],[@B15-nutrients-10-00555]\]. They also showed that calorie and protein intake are significantly lower in geriatric patients with hip fracture compared to patients without fracture. Both the reduced intake observed in hip fracture patients and the increase of the energy requirement secondary to the inflammatory state lead to weight loss and a reduction in muscle mass and fat tissue indicators, and this hypercatabolism situation may continue up to 4 months after the fracture \[[@B16-nutrients-10-00555],[@B17-nutrients-10-00555],[@B18-nutrients-10-00555]\].

The importance of a good nutritional status was backed up by studies that observed how higher BMI scores were associated with a lower incidence of hip fractures \[[@B19-nutrients-10-00555]\]. An interesting and original study showed that patients with intracapsular fractures presented lower BMI scores than patients with intertrochanteric fractures. Almost half of the subjects with intracapsular fractures presented BMI scores lower than 18 kg/m^2^, versus only one-fifth of patients with intertrochanteric fractures \[[@B20-nutrients-10-00555]\].

3.2. Influence upon Outcomes and Complications {#sec3dot2-nutrients-10-00555}
----------------------------------------------

The general characteristics of the studies included in this section can be found in [Table 3](#nutrients-10-00555-t003){ref-type="table"}.

Espaulella et al. showed how after 6 months' follow-up only slightly over half of the patients subject to follow-up had recovered the functional status they had before the fracture \[[@B36-nutrients-10-00555]\]. The MNA was an independent predictor of functional status upon discharge \[[@B30-nutrients-10-00555]\], at four and at 12 months \[[@B31-nutrients-10-00555]\]. Malnourished patients are more likely to suffer postoperative delirium \[[@B32-nutrients-10-00555]\], as well as other post-operative complications such as sepsis \[[@B21-nutrients-10-00555]\] and pressure ulcers \[[@B37-nutrients-10-00555]\].

Malnutrition is of double importance as it is a risk factor for hip fracture, and in patients with hip fracture it reduces the ability to recover pre-fracture functional capacity. Indeed, malnutrition is a risk factor for fracture, and malnourished older people generally present a worse functional status before the fracture and frequently recover only partially their pre-fracture level of independency in activities of daily living (ADL) following a hip fracture \[[@B27-nutrients-10-00555]\]. Conversely, well-nourished older people tend to improve their functional status at discharge after a hip fracture, as revealed by the motor-Functional Independence Measure (FIM) scale \[[@B30-nutrients-10-00555]\].

Malnutrition and risk of malnutrition are more prevalent in geriatric patients with a higher comorbidity \[[@B38-nutrients-10-00555]\], in addition to being risk factors for complications following hip fracture surgery, such as pressure ulcers \[[@B39-nutrients-10-00555]\].

Albumin could be a good blood marker of malnutrition \[[@B40-nutrients-10-00555]\]. In this context, Bohl et al. studied a large database (17,651 patients with hip fracture, mean age 84.4 ± 7.2 years) and observed a prevalence of malnutrition of 45.9%, defined as albumin values below 3.5 g/dL prior to surgery \[[@B21-nutrients-10-00555]\]. These authors reported that patients with hypoalbuminemia presented a higher prevalence of sepsis (*p* \< 0.001), longer hospital stay (*p* \< 0.001), and higher prevalence of readmission (*p* = 0.054). The benefits of a good nutritional status were also observed in other studies \[[@B18-nutrients-10-00555]\].

3.3. Malnutrition and Mortality in Older People with Hip Fractures {#sec3dot3-nutrients-10-00555}
------------------------------------------------------------------

In this section we included those studies whose main objective was to assess the impact of malnutrition, as revealed by nutritional biomarkers, on mortality. In addition, we considered studies where a multivariable analysis was carried out and which included malnutrition biomarkers. A summary of the design, characteristics, and main results of the included studies can be found in [Table 4](#nutrients-10-00555-t004){ref-type="table"}. We included five studies, with a total of 2518 patients (71.8% females), mean age 84.3 ± 7.2 years.

Mortality was inversely associated with pre-surgery albumin levels, and patients with hypoalbuminemia had a relative risk of dying of 1.52 (95% Confidence Interval (CI) 1.37--1.70, *p* \< 0.001) \[[@B21-nutrients-10-00555]\]. Regardless of the tool used to diagnose malnutrition, low values of albumin or BMI or low MNA were associated with an increase in mortality. Albumin concentrations of less than 36 g/L were associated with a 4-year mortality nearly six times greater (Odd-Ratio (OR) 5.85, 95% CI 2.3--16.5) \[[@B43-nutrients-10-00555]\]. Furthermore, BMI values of less than 22 kg/m^2^ were associated with an increase of almost seven times the mortality at 1 year, as compared to values higher than 25 kg/m^2^ (Hazard Ratio (HR) 7.25, 95% CI 1.6--33.7) \[[@B22-nutrients-10-00555]\]. Studies such as that of Flodin and collaborators confirm the anterior outcome, observing that subjects with a BMI greater than 26 kg/m^2^ had a risk almost three times less of dying after 1 year from the fracture (OR 2.6, 95%CI 1.4--5.0) \[[@B44-nutrients-10-00555]\].

Cenzer et al. showed that difficulty preparing meals after hip fracture predicts 1-year mortality (and this predictor factor has the same points as congestive heart failure) \[[@B45-nutrients-10-00555]\]. Others factors such as age, male sex, congestive heart failure, and not being able to drive complete the risk stratification scale \[[@B45-nutrients-10-00555]\].

Mortality increases progressively after a hip fracture, from an in-hospital mortality of 7%, to 11% in the first 6 months after the fracture, up to 30% in the first year and 40% at 3 years. To highlight the importance of this health problem, we summarized total mortality and the follow-up periods of the included studies in [Table 5](#nutrients-10-00555-t005){ref-type="table"}.

3.4. Effects of Nutritional Intervention {#sec3dot4-nutrients-10-00555}
----------------------------------------

In this section we included the studies in which nutritional interventions were carried out. The general characteristics of the populations included, the design, and the main results of the studies included are presented in [Table 6](#nutrients-10-00555-t006){ref-type="table"}.

We included 18 studies, 14 of which were carried out in Europe, one in the USA, one in Australia, and two in Asia, totaling 2248 patients (each study including between 23 and 420 subjects), with an mean age of 81.6 ± 5.4. Five studies were carried out only on women, whereas the rest had mixed samples (66.8% women).

A majority of the studies (*n* 14) used oral nutritional supplements. One was preceded by supplementation with parenteral nutrition. In one study the supplement was administered via naso-gastric tube, and in one other study only dietary advice was used. One study did not specify the type of intervention. The characteristics of the interventions, calories used, protein content, and duration of the treatment are summarized in [Table 7](#nutrients-10-00555-t007){ref-type="table"}.

Regarding duration, in seven studies intervention was maintained during hospital stay, in four studies the duration was ≤3 months, and in two it was up to 6 months. Two of the studies did not specify the duration of treatment.

The results demonstrated that a good compliance in the use of oral supplements was associated with an increase in total energy, protein, and liquid intake during hospital stay \[[@B16-nutrients-10-00555],[@B17-nutrients-10-00555],[@B23-nutrients-10-00555],[@B24-nutrients-10-00555],[@B48-nutrients-10-00555]\]. This is important because higher nutritional intake was associated with less postoperative complications. This improvement in intake brought on an increase of IGF-1, a decrease of bone loss 1 year after the fracture \[[@B50-nutrients-10-00555]\], lesser prevalence and intensity of delirium, and lower production of oxidative stress-derived products \[[@B23-nutrients-10-00555]\]. Nutritional supplementation could also lead to a decrease in the incidence and duration of pressure ulcers, as well as delay their onset. Weight loss was found among subjects who received no supplementation (the control group) \[[@B25-nutrients-10-00555],[@B51-nutrients-10-00555],[@B52-nutrients-10-00555]\], probably due to a loss of muscle mass \[[@B53-nutrients-10-00555],[@B54-nutrients-10-00555]\]. Two recent studies used supplements enriched with Calcium β-Hydroxy-β-Methylbutyrate (CaHMB); these studies observed an improvement in muscle indices in the intervention groups but no improvement in the control groups \[[@B54-nutrients-10-00555],[@B55-nutrients-10-00555]\].

A multidisciplinary approach is required in order to reduce malnourishment in subjects admitted to hospital \[[@B25-nutrients-10-00555]\]. Having a dietician on the team \[[@B49-nutrients-10-00555]\] as well as nurses trained in nutrition \[[@B25-nutrients-10-00555]\] was associated with an increase in energy, protein, and supplement intake. In addition, a multidisciplinary approach was shown to counteract increases in the incidence of malnutrition after discharge \[[@B25-nutrients-10-00555]\]. Furthermore, nutritional intervention was associated with lower short- and long-term mortality rate as well as with an increase in quality of life (as revealed by the EuroQol-5D scale) \[[@B25-nutrients-10-00555],[@B49-nutrients-10-00555]\]. Nutritional advice for well-nourished patients was associated with better performance in the ADL, and with a better recovery of the ability to walk \[[@B28-nutrients-10-00555]\].

4. Discussion {#sec4-nutrients-10-00555}
=============

Malnutrition is a subject under intense discussion in geriatric research \[[@B57-nutrients-10-00555],[@B58-nutrients-10-00555],[@B59-nutrients-10-00555]\], as it is very prevalent in older people with hip fracture, it negatively influences functional recovery after fracture, it increases healthcare spending, and it is associated with high mortality. It appears that nutritional intervention aids the prevention of complications in geriatric patients with hip fracture. This review is an attempt to summarize existing evidence of these aspects. To our knowledge, this is the first review to assess the nutritional status of older people with hip fracture and how it influences complications and mortality.

Despite the variability in the main objective of the included studies, the results are homogeneous in the evidence that subjects with hip fracture have anthropometric indices indicative of malnutrition ([Table 2](#nutrients-10-00555-t002){ref-type="table"}). In addition, there is evidence that subjects with worse nutritional status have more complications ([Table 3](#nutrients-10-00555-t003){ref-type="table"}) and increased mortality ([Table 4](#nutrients-10-00555-t004){ref-type="table"}). There is a lot of variability in the main objective, as well as in the type of nutritional intervention (dietary advice, use of nutritional supplements) and in the amount of calories used in the included studies ([Table 7](#nutrients-10-00555-t007){ref-type="table"}). Despite this variability in the methods used in the studies, overall nutritional intervention has been shown to reduce complications and avoid weight loss in elderly subjects with hip fracture ([Table 6](#nutrients-10-00555-t006){ref-type="table"}).

The prevalence of malnutrition in older patients with hip fracture is higher than in community-dwelling older adults \[[@B60-nutrients-10-00555],[@B61-nutrients-10-00555]\]. A further problem was associated with an increase in calorie expenditure, secondary to systemic inflammatory response, without a corresponding intake increase, whereby nutritional intake remained smaller than requirements due to factors such as pain, being bedridden, and reduced mobility \[[@B25-nutrients-10-00555],[@B49-nutrients-10-00555]\].

A reduction in intake is often observed in older people, causing it to be lower than requirements \[[@B57-nutrients-10-00555]\]. These changes in intake have a multi-factor origin, among which the most frequent factors are alterations in sensory organs, loss of teeth, lack of a principal caregiver, and, in some cases, the adverse effects of certain drugs \[[@B62-nutrients-10-00555]\]. These intake alterations constitute a well-known geriatric syndrome defined as anorexia of ageing \[[@B63-nutrients-10-00555]\]. Calorie and/or protein deficits can contribute to the pathophysiology of fractures, especially through two mechanisms: (1) loss of strength and muscle mass (sarcopenia), which increases the risk of falls; and (2) low bone mineral density (osteoporosis), which reduces the resistance of bones to trauma, increasing the risk of fracture \[[@B1-nutrients-10-00555]\].

The observed variability in the parameters of nutritional status in hip fracture patients could be due to the lack of a universal consensus as to the best measure to diagnose protein-energy malnutrition. This lack of universality limits our comparison of the various studies, also making it difficult to carry out a consistent malnutrition diagnosis, which, in certain cases, can delay the clinical decision to prescribe nutritional treatment for these patients.

Despite this, the observed trend is uniform and shows that malnourished older people are at a greater risk of fracture and that the prevalence of malnutrition is high in geriatric patients admitted with hip fracture. Patients with intracapsular fracture usually have low BMI, while patients with trochanteric fracture tend to have high BMI \[[@B20-nutrients-10-00555],[@B64-nutrients-10-00555]\]. Low BMI is associated with protein deficit (type II nutrients, important for maintaining weight) and type I nutrients are important for bone metabolism. In relation to this, "BMI paradox" is valid in the elderly, in which an increase in fat mass and a decrease of muscle mass are observed, and for this reason falsely high values of BMI can mask the presence of sarcopenia \[[@B65-nutrients-10-00555]\]. Despite the important limitations of the prognostic meaning of BMI in the elderly, this remains a fundamental index to assess the nutritional status for its simplicity and repeatability, and most validated nutrition assessment tools include BMI. Recent articles have proposed that the normal cut-off considered by the World Health Organization (WHO) (18.5--20.0 kg/m^2^) should be modified with the values that have been shown to be associated with lower mortality in the elderly (23--29 kg/m^2^) \[[@B66-nutrients-10-00555]\]. It would be advisable to complete the nutritional assessment by evaluating the body composition (with dual-energy absorptiometry (DXA) or with bioimpedance analysis) \[[@B67-nutrients-10-00555],[@B68-nutrients-10-00555]\]. The problem is different if we consider the concentration of albumin for the diagnosis of malnutrition. The blood concentration of albumin may be a good nutritional index if the inflammatory state is taken into account, considering that its concentration does not depend only on nutritional status \[[@B40-nutrients-10-00555]\]. On the other hand, albumin has been shown to be a good prognostic index in hospitalized patients \[[@B69-nutrients-10-00555]\].

Screening tools such as the Mini-Nutritional Assessment Short-Form (MNA-SF) were able to diagnose a nutritional problem before it manifested through changes in the biochemical markers of malnutrition (such as albumin or total protein) \[[@B70-nutrients-10-00555]\]. Factors such as cognitive impairment and disability in the basic activities of daily living (ADL) were associated with lower scores in the MNA-SF \[[@B71-nutrients-10-00555]\]. This tool was also shown to be a predictive factor of destination upon discharge following the fracture \[[@B72-nutrients-10-00555]\]. Selective deficiencies such as lack of vitamin D are very prevalent in older people \[[@B73-nutrients-10-00555]\].

As well as the known effects of this deficiency on bone metabolism, there is a high concentration of vitamin D receptors in muscle tissue \[[@B7-nutrients-10-00555]\]. This situation could explain why the lack of this vitamin (scant diet input, little exposure to the sun, and the ability to make vitamin D within the skin declines with age) is so obviously associated with reduced muscle strength and a worse functional status, involving factors that increase the risk of fall and fracture \[[@B42-nutrients-10-00555]\].

The high prevalence of malnutrition in people with dementia could be one of the pathophysiological mechanisms for the high risk of falls and fractures, as well as for their poor functional recovery after a fracture \[[@B27-nutrients-10-00555],[@B37-nutrients-10-00555],[@B42-nutrients-10-00555],[@B74-nutrients-10-00555]\]. People with dementia suffered an increase in incidence of hip fracture, as dementia is a risk factor for hip fracture \[[@B75-nutrients-10-00555]\]. Strategies for the prevention of hip fractures are very important in people with dementia because they present a higher prevalence of complications, higher risk of institutionalization, and worse functional recovery \[[@B3-nutrients-10-00555]\]. Moreover, dementia is an independent predictor for mortality \[[@B76-nutrients-10-00555]\].

Malnutrition, which is very prevalent in geriatric patients with hip fracture, is associated with the incidence of complications, with length of hospital stay (and thus increase in cost), and with mortality. Hip fracture continues to be a pathology with high mortality. In spite of the achievement of a reduction in the incidence of hip fractures, mortality has not decreased \[[@B77-nutrients-10-00555]\]. Intra-hospital mortality of elderly patients with hip fracture (7.4%) is comparable with mortality of elderly patients with heart failure (8%) \[[@B78-nutrients-10-00555]\]. The problem is that hip fracture represents an acute potentially preventable disease, for example by implanting exercise programs that have been shown to reduce the risk of falling \[[@B79-nutrients-10-00555]\]. It will be necessary to improve the post-surgical treatment to reduce complications and mortality, which at 3 years is almost twice that of patients with heart failure \[[@B80-nutrients-10-00555],[@B81-nutrients-10-00555]\].

Patients with hip fracture show a state of hypercatabolism secondary to reduced intake, loss of blood, and inflammation, which leads to a reduction in plasma proteins, which are important mechanisms for the defense of oxidative stress. Cell regeneration determines an increase in the production of free radicals at the site of the fracture. Plasma oxidant markers malondialdehyde (MDA) and advanced oxidation protein products (AOPP) were significantly positively, while albumin and total antioxidant capacity (TAC) are significantly negatively associated with the duration of hospitalization.

Several studies observed lower scores in nutritional indices, such as BMI, in geriatric patients who died following a hip fracture, as compared to those who lived \[[@B82-nutrients-10-00555]\]. It may be possible to reduce mortality with adequate nutritional intervention \[[@B49-nutrients-10-00555]\]. A difficult question to answer is whether nutritional supplementation is indicated for all patients with hip fracture or only for malnourished patients. Supplementation prevented weight loss in both malnourished and well-nourished patients. This association was directly related to the dose administered \[[@B51-nutrients-10-00555]\]. A higher protein intake was associated with a lower risk of post-surgery complications \[[@B24-nutrients-10-00555]\], and an adequate energy intake reduced the development of complications and was associated with a shorter duration of hospital stay \[[@B17-nutrients-10-00555]\].

Therefore, the results of this review support the indications of the European Society of Parenteral and Enteral Nutrition (ESPEN) guidelines, according to which all older adult patients with hip fracture should receive nutritional supplements during hospitalization \[[@B83-nutrients-10-00555]\].

5. Conclusions {#sec5-nutrients-10-00555}
==============

The prevalence of malnutrition is very high in older people and increases further in older people with high comorbidities as well as in geriatric patients. Malnutrition is associated to functional alterations and this can be a cause as well as a consequence of fractures.

Malnutrition prevention could be associated with a reduction in the incidence of fractures, and with a better functional recovery following hip fracture. Fall prevention campaigns as well as advice on healthy and active ageing have contributed to the reduction in the incidence of hip fractures. The inclusion in care plans for geriatric patients with hip fracture of both nutritional assessments and the treatment of malnutrition could contribute to a better functional recovery and a reduction of mortality.

The following are available online at <http://www.mdpi.com/2072-6643/10/5/555/s1>, Table S1: Results of quality assessment of the observational included studies, Table S2: Results of quality assessment of included intervention studies.
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nutrients-10-00555-t001_Table 1

###### 

Prevalence of malnutrition or risk of malnutrition and nutritional screening tool used in the included studies.

  ------------------------------- ------------ --------- ---------- --------- ----------------------------------------------------------------
  **Reference**                   **Total**\   **WN**\   **RMN**\   **MN**\   **Cut-Off for Malnutrition**
                                  ***n***      ***n***   ***n***    ***n***   

  \[[@B21-nutrients-10-00555]\]   17,651       9549      \-         8102      Albumin \< 3.5 g/dL

  \[[@B22-nutrients-10-00555]\]   173          49        \-         57        BMI \< 22 kg/m^2^

  \[[@B23-nutrients-10-00555]\]   23           9         7          7         BMI ^†^

  \[[@B20-nutrients-10-00555]\]   96           59        \-         37        BMI \< 18.5 kg/m^2^

  \[[@B24-nutrients-10-00555]\]   60           34        \-         26        Weight loss ≥ 5% 1 m, or ≥ 10% 6 m, and/or albumin \< 2.7 g/dL

  \[[@B14-nutrients-10-00555]\]   25           11        11         3         Hospital's own screening tool ^§^

  Total of subjects               18,028       9711      18         8232      

  Percentage                                   53.9%                45.7%     

  **Reference**                   **Total**\   **WN**\   **RMN**\   **MN**\   **Cut-Off for Malnutrition**
                                  ***n***      ***n***   ***n***    ***n***   

  \[[@B15-nutrients-10-00555]\]   49           18        23         8         MNA ^‡^

  \[[@B19-nutrients-10-00555]\]   80           38        35         7         MNA

  \[[@B25-nutrients-10-00555]\]   127          89        36         2         MNA

  \[[@B17-nutrients-10-00555]\]   50           32        18         0         MNA

  \[[@B26-nutrients-10-00555]\]   50           7         29         14        MNA

  \[[@B27-nutrients-10-00555]\]   97           44        37         16        MNA

  \[[@B28-nutrients-10-00555]\]   162          59        \-         103       MNA

  \[[@B29-nutrients-10-00555]\]   152          87        \-         65        MNA

  \[[@B18-nutrients-10-00555]\]   215          95        95         25        MNA-SF ^¥^

  \[[@B30-nutrients-10-00555]\]   204          55        98         51        MNA-SF

  \[[@B31-nutrients-10-00555]\]   594          316       236        42        MNA-SF

  \[[@B32-nutrients-10-00555]\]   415          152       185        78        MNA-SF

  Total of subjects               2195         992       774        411       

  Percentage                                   45.2%     35.3%      18.7%     
  ------------------------------- ------------ --------- ---------- --------- ----------------------------------------------------------------

^§^ This screening tool is based on changes in dietary intake, weight, and other risk factors (pressure ulcers, presence of infection, period of fasting, and the need for help with eating and drinking); ^†^ Risk of malnutrition cut-off point: Body Mass Index (BMI) between 20 and 22 kg/m^2^; ^‡^ Mini-Nutritional Assessment (MNA) cut-off points: well-nourished ≥ 24 points, at risk for malnutrition at 17--23.5 points, and malnourished at less than 17 points; ^¥^ Mini-Nutritional Assessment-Short Form (MNA-SF) cut-off points: well-nourished 12--14 points, at risk of malnutrition 8--11 points, and malnourished 0--7 points; WN: well-nourished; RMN: risk of malnutrition; MN: malnourished.

nutrients-10-00555-t002_Table 2

###### 

Nutritional status and biomarkers in patients with hip fracture.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors\                             Design\                                                                                                                                                 *n* (Male/Female)\         Anthropometry\                             \(1\) Exclusion Criteria\                                                                        Main Outcomes
  Origin\                              Aim\                                                                                                                                                    Age, Mean ± SD (Years)\    Measurement of Body Composition\           (2) Definition of Malnutrition                                                                   
  Publication Year                     Setting                                                                                                                                                 BMI (kg/m^2^)              Biomarkers                                                                                                                                  
  ------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------- ------------------------------------------ ------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------
  Mansell\                             Observational\                                                                                                                                          *n* 663 (0/663)\           MAC (cm)\                                  \(1\) For healthy female: housebound or wheelchairs\                                             Fractured group were older than healthy subjects (*p* \< 0.001).\
  UK\                                  Comparison of anthropometric measurements of women with HF, with healthy volunteers in the community (C) and patients admitted to geriatric wards (G)   HF 470\                    HF 22.8 ± 0.2\                             (2) NA                                                                                           HF vs. Community: ↓ MAC ↓ AMA ↓↓ TSF ↓↓ AFA (*p* \< 0.001)\
  1990 \[[@B33-nutrients-10-00555]\]                                                                                                                                                           Community 103\             Community 28.6 ± 0.27\                                                                                                                      Significant MAC reduction per year of age:\
                                                                                                                                                                                               Geriatric 90               Geriatric 25.9 ± 0.41                                                                                                                       −0.20 ± 0.03 cm/year (HF)\
                                                                                                                                                                                                                                                                                                                                                                      −0.15 ± 0.06 cm/year (Community)\
                                                                                                                                                                                                                                                                                                                                                                      Significant TSF reduction per year of age:\
                                                                                                                                                                                                                                                                                                                                                                      −0.16 ± 0.03 mm/year (HF)

  HF = 77.3 ± 0.3 years\               TSF (mm)\                                                                                                                                                                                                                                                                                                                      
  Community 72.5 ± 0.5 years\          HF 13.0 ± 0.6\                                                                                                                                                                                                                                                                                                                 
  Geriatric 79.1 ± 0.8 years           Community 24.7 ± 0.6                                                                                                                                                                                                                                                                                                           

  Maffulli\                            Observational\                                                                                                                                          *n* 119 (91/28)\           **Intertrochanteric** TSF 11.6 ± 4.5 mm\   \(1\) Pathologic fracture\                                                                       Malnourished → 45% IC vs. 20% IT (p \< 0.001)\
  UK\                                  Nutritional differences in patients with intertrochanteric (IT) and intracapsular (IC) fractures                                                        IT 17--54\                 BSF 6.1 ± 4 mm\                            (2) BMI \< 18 kg/m^2^                                                                            19% Overweight or obese → 22% IT vs. 2% IC\
  1999 \[[@B20-nutrients-10-00555]\]                                                                                                                                                           IC 11--37\                 MAC 23.5 ± 3.6 cm\                                                                                                                          Complications 15% IC vs. 3% IT (*p* \< 0.05)\
                                                                                                                                                                                               80.8 ± 9.1 years\          **Intracapsular** TSF 10.6 ± 4 mm\                                                                                                          BMI: IC \< IT (20.1 ± 3.3 vs. 22.5 ± 4.6 kg/m^2^, *p* \< 0.01)
                                                                                                                                                                                               21.5 ± 4.1 kg/m^2^         BSF 5.4 ± 2.4 mm\                                                                                                                           
                                                                                                                                                                                                                          MAC 21.9 ± 3.1cm                                                                                                                            

  Murphy\                              Observational\                                                                                                                                          *n* 49 (0/49)\             Albumin 36.9 ± 4.7 g/L                     \(1\) Cognitive impairment\                                                                      Patients had low mean values for body weight, albumin and transferrin\
  UK\                                  Assess the sensitivity and specificity of MNA, and its comparability with other nutritional tools                                                       79.5 ± 9 years\                                                       (2) MNA                                                                                          Mean energy intake was below the estimated average requirementMNA \< 17:\
  2000 \[[@B15-nutrients-10-00555]\]                                                                                                                                                           23.7 ± 4.3 kg/m^2^                                                                                                                                                     Sensitivity: 27--57%\
                                                                                                                                                                                                                                                                                                                                                                      Specificity: 66--100%

  Lumbers\                             Cross-sectional\                                                                                                                                        *n* 125\                   **HF**\                                    \(1\) Mental function test \< 7\                                                                 HF patients vs. day center attendees have:\
  UK\                                  Intake and nutritional status in\                                                                                                                       HF 75 (0/75)\              MAC 27.1 ± 4.3 cm\                         (2) NA                                                                                           lower BMI (24.1 ± 4.7 vs. 27.5 ± 4.9 kg/m^2^, *p* \< 0.001); lower MUAMC, albumin, proteins and energy intake and higher CRP (*p* \< 0.01)\
  2001 \[[@B12-nutrients-10-00555]\]   HF compared to day center attendees (DC)                                                                                                                DC 50 (0/50)\              TSF 17 ± 2.7 mm\                                                                                                                            Albumin ↔ RCP (*r* = −0.45)
                                                                                                                                                                                               80.2 ± 7.9 years\          MUAMC 21.4 ± 3.4 cm\                                                                                                                        
                                                                                                                                                                                               25.5 ± 4.8 kg/m^2^         **Day Centers**\                                                                                                                            
                                                                                                                                                                                                                          MAC 31.3 ± 4.7 cm\                                                                                                                          
                                                                                                                                                                                                                          TSF 18.9 ± 2.8 mm\                                                                                                                          
                                                                                                                                                                                                                          MUAMC 23.3 ± 3.8 cm                                                                                                                         

  Nematy\                              Observational\                                                                                                                                          *n* 25 (7/18)\             Albumin 36 ± 2.6 g/L                       \(1\) Pathological fracture or elective surgery\                                                 At risk of malnutrition group (*n* 17) had lower BMI and lower energy intake versus well-nourished group (*n* 8)\
  UK\                                  Nutritional status and energy intake                                                                                                                    85.3 ± 1.5 years\                                                     (2) Changes in dietary intake, weight loss, pressure sore, infection, and need help for eating   BMI: ARM 19.6 ± 1.1 vs. WN 25 ± 1.5 kg/m^2^\
  2006 \[[@B14-nutrients-10-00555]\]                                                                                                                                                           21.9 ± 1.0 kg/m^2^                                                                                                                                                     Energy intake: ARM 3602 ± 320 vs. WN 5044 ± 528 kJ/day

  Perez\                               Observational\                                                                                                                                          *n* 80 (24/56)\            TSF 5.5 ± 2.3 mm\                          \(1\) NA\                                                                                        Length of hospital stay: men 15.3 ± 5.8 days; women 14.9 ± 12 days\
  Spain\                               Prevalence of malnutrition                                                                                                                              80.6 ± 6.3 years\          BSF 8.1 ± 4.8 mm\                          (2) MNA                                                                                          MNA ↔ BMI *r* = 0.6
  2010 \[[@B19-nutrients-10-00555]\]                                                                                                                                                           27.1 ± 4.4 kg/m^2^         MAC 26.8 ± 3.9 mm\                                                                                                                          
                                                                                                                                                                                                                          CC 31.9 ± 4 cm                                                                                                                              

  Perez\                               Observational\                                                                                                                                          *n* 86 (0/86)\             **MAC (cm)**\                              \(1\) No osteoporotic fractures or major trauma\                                                 HF has lower BMI, arm and leg circumference than community dwelling (*p* \< 0.05)\
  Spain\                               Nutritional status and intake of HF vs. community dwelling study participants                                                                           HF = 44\                   HF 27.3 ± 3.2\                             (2) NA                                                                                           Energy intake (kcal): HF 1417; community dwelling 2052 (*p* \< 0.001)\
  2011 \[[@B13-nutrients-10-00555]\]                                                                                                                                                           Community = 42             Community 29.1 ± 4.1                                                                                                                        Calcium (mg/dL): HF 827; community dwelling 1265 (*p* \< 0.001)\
                                                                                                                                                                                                                                                                                                                                                                      Vitamin D (μg/dL): HF 1.6; community dwelling: 5.2 (*p* \< 0.001)

  **Age**\                                                                                                                                                                                                                                                                                                                                                            
  HF = 77.9 ± 4.7 years\                                                                                                                                                                                                                                                                                                                                              
  Community = 76.2 ± 4.6 years                                                                                                                                                                                                                                                                                                                                        

  **Calf circumference (cm)**\                                                                                                                                                                                                                                                                                                                                        
  HF 32.5 ± 3.6\                                                                                                                                                                                                                                                                                                                                                      
  Community 35.1 ± 4.4                                                                                                                                                                                                                                                                                                                                                

  **BMI kg/m^2^**\                                                                                                                                                                                                                                                                                                                                                    
  HF = 27.6 ± 3.7\                                                                                                                                                                                                                                                                                                                                                    
  Community = 31.3 ± 4.6                                                                                                                                                                                                                                                                                                                                              

  Koren-Hakim\                         Retrospective\                                                                                                                                          *n* 215 (61/154)\          WN28.1 ± 4.0 kg/m^2^\                      \(1\) Terminal illnesses and multi-trauma\                                                       MNA ↔ BMI, ADL, cognitive status, readmission, mortality 36 m, CCI and CIRS-G\
  Israel\                              Association of MNA-SF with functional status, comorbidity, and mortality (36 months)                                                                    83.5 ± 6.1 years\          ARM 25.5 ± 5.1 kg/m^2^\                    (2) MNA                                                                                          Independent variables for mortality → Charlson comorbidity index and functional status (ADL)
  2012 \[[@B18-nutrients-10-00555]\]                                                                                                                                                           26.4 ± 4.9 kg/m^2^         MN 22.7 ± 3.7 kg/m^2^                                                                                                                       

  Villani\                             Cross-sectional\                                                                                                                                        *n* 71(19/52)\             M:\                                        \(1\) Pathological fracture or malignancy, residing in residential care\                         Patients with cachexia:\
  Germany\                             Evaluate new screening tool for detection cachexia                                                                                                      82.2 ± 5.8 years\          MAC (cm) 26.7 ± 3.3\                       (2) NA                                                                                           5 new tool\
  2013 \[[@B34-nutrients-10-00555]\]                                                                                                                                                           Men 23.9 ± 2.9 kg/m^2^\    TSF (mm) 11.5 ± 4.8\                                                                                                                        4 (consensus definition)\
                                                                                                                                                                                               Women 25.9 ± 3.8 kg/m^2^   W:\                                                                                                                                         New tool:\
                                                                                                                                                                                                                          MAC (cm) 27.1 ± 3.9\                                                                                                                        Sensitivity 75% and specificity 97%\
                                                                                                                                                                                                                          TSF (mm) 16.4 ± 5.4                                                                                                                         Positive predictive value 60%, negative predictive value 99%

  Bell\                                Prospective\                                                                                                                                            *n* 142 (45/97)\           NA                                         \(1\) NA\                                                                                        Malnutrition prevalence with different tools: BMI (12.7%), MNA-SF (27%), ICD10-AM (48.2%), Albumin (53.2%), subjective assessment (55.1%)\
  Australia\                           Concurrent and predictive validity of malnutrition diagnostic measures                                                                                  83.5 years                                                            (2) MNA-SF \< 8\                                                                                 MNA-SF ↔ ICD10-AM (*r* = 0.3) and BMI (*r* = 0.2)\
  2014 \[[@B35-nutrients-10-00555]\]                                                                                                                                                                                                                                 BMI \< 18.5 kg/m^2^\                                                                             ICD10-AM ↔ subjective assessment (*r* = 0.6)\
                                                                                                                                                                                                                                                                     ALB \< 35 g/L\                                                                                   ICD10-AM independent predictor of 4-month mortality (OR 3.6, 95%CI 1.1--11.8)
                                                                                                                                                                                                                                                                     ICD10-AM\                                                                                        
                                                                                                                                                                                                                                                                     Geriatrician (subjective clinical assessment)                                                    
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ADL: activities of daily living; AFA: arm fat area; AMA: arm muscle area; ARM: at risk of malnutrition; BMI: body mass index; BSF: biceps skinfold; CIRS-G: cumulative illness rating scale for geriatrics; CRP: C-reactive protein; HF: hip fracture; ICD10-AM: international classification of disease 10th revision-Australian modification; MAC: mid-arm circumference; MN: malnourished; MNA: Mini Nutritional Assessment; MUAMC: mid-upper arm muscle circumference; TSF: triceps skinfold; WN: well-nourished. . ↓: lower; ↓↓ much lower; ↔: correlation.

nutrients-10-00555-t003_Table 3

###### 

Association of nutritional status, as revealed by nutritional biomarkers, with outcomes and post-operative complications.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors\                             Design\                                                                            *n* (Male/Female)\          BMI (kg/m^2^)\                    Exclusion Criteria\                                                                                                                          Main Outcomes
  Origin                               Aim                                                                                Age, Mean ± SD (Years)      Biomarkers                        MN Definition Tool                                                                                                                           
  ------------------------------------ ---------------------------------------------------------------------------------- --------------------------- --------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Formiga\                             Prospective observational\                                                         *n* 73 (12/61)\             Cholesterol 4.3 ± 1.1 mmol/L\     Pathological or multiple fractures, terminally ill patients, surgery delayed\                                                                MNA-SF → 11 ± 0.5\
  Spain\                               Relationship between nutritional status and complications                          81.5 ± 7.1 years            Albumin 30.6 ± 3.6 g/L\           \>48 h or lipid-lowering drug\                                                                                                               MNA-SF not predict → nosocomial infections and pressure ulcers\
  2005 \[[@B41-nutrients-10-00555]\]                                                                                                                  TLC/mm^3^ 1278 ± 463              MNA-SF \<11                                                                                                                                  Albumin predict → nosocomial infections\
                                                                                                                                                                                                                                                                                                                                     ↓ TLC years ↓ Albumin predict → pressure ulcers\
                                                                                                                                                                                                                                                                                                                                     Barthel index ↔ Charlson comorbidity index *r* = −0.9 (*p* \< 0.0001)\
                                                                                                                                                                                                                                                                                                                                     Length of hospital stay = 16.4 days

  Montero\                             Prospective cohort\                                                                *n* 110 (22/88)\            25(OH)vitD 10.8 ± 5.3 ng/ml\      Pathologic or major trauma fractures\                                                                                                        38.8% regained pre-fracture functional state\
  Spain\                               Relationship\                                                                      81.4 ± 7.3 years            TLC/ mm^3^ 1545 ± 592\            Anthropometric and blood biomarkers                                                                                                          Dementia ↔ ↓ functional recovery\
  2007 \[[@B42-nutrients-10-00555]\]   between malnutrition and recovery                                                                              Albumin 32.6 ± 3.8 g/L\                                                                                                                                                        25(OH)vit D \<10 ng/ml ↔ ↓ pre-fracture functional state, with bedridden (1 year) and with no functional recovery (*p* \< 0.05)\
                                                                                                                                                      Prealbumin 15.3 ± 4.7 mg/dL\                                                                                                                                                   Factors associated to bedridden (1 year) OR, 95%CI\
                                                                                                                                                      Cholesterol 160.5 ± 40.8 mg/dL\                                                                                                                                                -pre-fracture functional status 10.02, 2.83--35.47 *p* \< 0.01-Caloric malnutrition 9.57 (2.18--42.84) *p* \< 0.01-Protein malnutrition 15.23 (1.36--1.70) *p* \< 0.05
                                                                                                                                                      Transferrin 195.9 ± 47.1 mg/dL                                                                                                                                                 

  Baumgarten\                          Prospective cohort\                                                                *n* 658 (152/506)\          23.8 ± 5.1 kg/m^2^                Fractures occurred during hospital stay\                                                                                                     Pressure ulcers at baseline ↔ ↑ severe illness, ↑ comorbidity, ↓ nutritional status, ↓cognitive status (*p* \< 0.05)\
  USA\                                 Identify care settings associated with increased pressure ulcers risk              83.2 ± 6.6 years                                              Subjective Global Assessment (SGA)                                                                                                           Albumin \< 30 g/L: 31.5%\
  2009 \[[@B37-nutrients-10-00555]\]                                                                                                                                                                                                                                                                                                 Length of hospital stay 5.6 ± 2.8 (no pressure ulcers) vs. 6.6 ± 3.8 (pressure ulcers) (*p* \< 0.001)

  Drevet\                              Prospective observational\                                                         *n* 50 (15/35)\             22.6 ± 4.3 kg/m^2^                Road accident\                                                                                                                               Prevalence of PEM was 28% (*n* 14)\
  France\                              Protein Energy Malnutrition prevalence                                             86.1 ± 4.4 years                                              MNA                                                                                                                                          Mean hospital stay: PEM 21.9 ± 16.7 vs. 13.4 ± 6.7 in non-PEM (*p* = 0.012)
  2014 \[[@B26-nutrients-10-00555]\]                                                                                                                                                                                                                                                                                                 

  Goisser\                             Observational\                                                                     *n* 97 (20/77)\             NA                                Terminal state, cancer-related pathologic fractures, cancer with acute radiation or chemotherapy\                                            Patients at risk for malnutrition and malnourished:\
  Germany\                             Relationship between nutritional status (MNA) and functional and clinical course   84 ± 5 years                                                  MNA                                                                                                                                          -Baseline, ↑ comorbidities ↑ Charlson comorbidity index ↑ pressure ulcers ↓ cognitive status (*p* \< 0.05)-All times, ↓ ADL score (*p* \< 0.05)-68% did not regain pre-fracture ADL-18% did not regain pre-fracture mobility level (*p* = 0.02)
  2015 \[[@B27-nutrients-10-00555]\]                                                                                                                                                                                                                                                                                                 

  Bohl\                                Retrospective\                                                                     *n* 17,651 (12,595/5056)\   24.6 ± 5.6 kg/m^2^\               Preoperative serum albumin concentration not available\                                                                                      18.5% had BMI \< 20 kg/m^2^\
  USA\                                 Association between albumin with death, and postoperative complications            84.4 ± 7.2 years            Albumin 35 ± 5 g/dL               Albumin concentration                                                                                                                        Patients with hypoalbuminemia had higher rates:\
  2017 \[[@B21-nutrients-10-00555]\]                                                                                                                                                                                                                                                                                                 -of death (RR 1.52. 95%CI 1.37--1.70. *p* \< 0.001)-of sepsis (RR 1.92. 95%CI 1.36--2.72. *p* \< 0.001)-of longer legnth of hospital stay, 5.7 ± 4.7 vs. 5.0 ± 3.9 days (*p* \< 0.001)

  Helminen\                            Prospective\                                                                       *n* 594 (169/425)\          24.9 kg/m^2^\                     Pathological or periprosthetic fractures, institutionalization, prefecture inability to walk\                                                All nutritional measures were significantly associated with mortality\
  Finland\                             Prognostic significance of MNA and albumin                                         84 years                    Albumin 33.5 g/L                  MNA-SF                                                                                                                                       Being at risk for malnutrition or being malnourished were significantly associated with impaired mobility at 4 months and 1 year
  2017 \[[@B31-nutrients-10-00555]\]                                                                                                                                                                                                                                                                                                 

  Mazzola\                             Prospective\                                                                       *n* 415 (104/309)\          NA\                               Nonoperative approach and preoperative delirium\                                                                                             Risk to develop postoperative delirium:\
  Italy\                               If nutritional status predict postoperative delirium                               84 ± 6.6 years              Albumin 33 ± 5.4 g/L              MNA-SF                                                                                                                                       -at risk for malnutrition: OR 2.42, 95%CI 1.29--4.53-malnourished: OR 2.98, 95%CI 1.43--6.19
  2017 \[[@B32-nutrients-10-00555]\]                                                                                                                                                                                                                                                                                                 

  Inoue\                               Prospective\                                                                       204 (39/165)\               20.2 ± 2.5 kg/m^2^\               Terminal disease, chronic liver disease, pre-fracture ambulation difficulty, no weight-bearing, discontinued postoperative rehabilitation\   Well-nourished had higher motor-FIM score at discharge\
  Japan\                               Relationship between nutritional status and functional recovery                    82.7 ± 9.2 years            Albumin 36 ± 9 g/L                MNA-SF                                                                                                                                       Motor-FIM at discharge was significant associated with MNA-SF
  2017 \[[@B30-nutrients-10-00555]\]                                                                                                                                                                                                                                                                                                 
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ADL: activities of daily living; BMI: body mass index; FIM: functional Independence Measure; HF: hip fracture; MNA: Mini Nutritional Assessment; PEM: protein energy malnutrition; OR: odd-ratio; 95%CI: 95% confidence interval. ↔: correlation.

nutrients-10-00555-t004_Table 4

###### 

Relationship between nutritional status and mortality.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors\                                            *n* (Male/Female)\            BMI kg/m^2^ (Mean ± SD)      Exclusion Criteria                                         Main Outcomes
  Origin\                                             Age, Mean ± SD (Years)                                                                                                
  Year\                                                                                                                                                                     
  Design                                                                                                                                                                    
  --------------------------------------------------- ----------------------------- ---------------------------- ---------------------------------------------------------- -----------------------------------------------------------------------------------------------------
  Miyanishi\                                          *n* 129 (24/103)\             21 ± 2.9 (Survivors)\        NA                                                         Non-survivors have:\
  Japan\                                              79 years\                     18.9 ± 3.5 (Non Survivors)                                                              ↓\* BMI, hemoglobin, albumin and ↑\* dementia, complications\
  2010\                                               Survivors 78 ± 11 years\                                                                                              Mortality predictors (4-year mortality):\
  Retrospective \[[@B43-nutrients-10-00555]\]         Non-survivors 81 ± 10 years                                                                                           Albumin (\<36 g/L) OR = 5.85 and BMI (\<18.9 kg/m^2^); OR = 1.16

  Schaller\                                           *n* 173 (36/137)\             NA                           Severe cognitive impairment (MMSE \> 15) or delirium       Risk factor for ↑mortality (1-year mortality):\
  Switzerland\                                        84.2 ± 6.7 years                                                                                                      MMSE \<25 (HR = 5.77, 95%CI: 1.55--21.55)\
  2012\                                                                                                                                                                     Male sex (HR = 3.55, 95%CI: 1.26--97)\
  Sub-analysis of RCT \[[@B22-nutrients-10-00555]\]                                                                                                                         BMI \<22 vs. \>25 (HR = 7.25, 95%CI: 1.61--33.74)\
                                                                                                                                                                            Vitamin D per 1ng/ml (HR = 0.93, 95%CI: 0.87--0.998)

  Gumieiro\                                           *n* 86 (20/66)\               NA                           Pathological fracture                                      MNA ↔ gait impairment OR = 0.77 (0.66--0.90) *p* = 0.001\
  Brasil\                                             80.2 ± 7.3 years                                                                                                      ↑ 1 point MNA → ↑\* 29% chance of walking\
  2013\                                                                                                                                                                     MNA ↔ mortality HR = 0.87 (0.76--0.99) *p* = 0.04\
  Prospective \[[@B46-nutrients-10-00555]\]                                                                                                                                 ↑ 1 point MNA → ↓\* 15% mortality risk

  Flodin\                                             *n* 843 (227/616)\            22.7 ± 3.8 kg/m^2^           Severe cognitive impairment, admitted from nursing-homes   1-year mortality (*p* = 0.006):\
  Sweden\                                             82 ± 7 years                                                                                                          BMI \> 26 = 6%\
  2016\                                                                                                                                                                     BMI 22--26 = 18%\
  Prospective \[[@B44-nutrients-10-00555]\]                                                                                                                                 BMI \< 22 = 16%\
                                                                                                                                                                            BMI \> 26 indicates a higher likelihood of returning to independent living (OR 2.6, 95%CI 1.4--5.0)

  Uriz-Otano\                                         *n* 430 (97/333)\             NA                           Tumor, high impact fracture                                3-year mortality:\
  Spain\                                              84.2 ± 7.4 years                                                                                                      Albumin HR 0.61, 95%CI 0.42--0.90\
  2016\                                                                                                                                                                     Predictors of 3-year mortality:\
  Prospective \[[@B47-nutrients-10-00555]\]                                                                                                                                 Age, HR 1.04, 95%CI 1.01--1.06\
                                                                                                                                                                            Comorbidity, HR 1.19, 95%CI 1.09--1.30\
                                                                                                                                                                            Complications, HR 1.17, 95%CI 1.05--1.31
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MMSE: Mini-Mental State Examinatio; RCT: randomized clinical trial; ↓\*: significantly less; ↑\*: significantly more.

nutrients-10-00555-t005_Table 5

###### 

Total mortality during hospital stay, and at various stages after discharge.

  Reference                       In-Hospital   \<6 Months   1 Year   36 Months   \>36 Months   *n*
  ------------------------------- ------------- ------------ -------- ----------- ------------- --------
  \[[@B18-nutrients-10-00555]\]   6%                                  36.7%                     215
  \[[@B20-nutrients-10-00555]\]   6%                                                            119
  \[[@B21-nutrients-10-00555]\]   7.4%                                                          17,651
  \[[@B22-nutrients-10-00555]\]                              27%                                173
  \[[@B27-nutrients-10-00555]\]   15%                                                           97
  \[[@B29-nutrients-10-00555]\]                 7.70%                                           152
  \[[@B31-nutrients-10-00555]\]                 30%          26%                                594
  \[[@B35-nutrients-10-00555]\]   4.9%          14.8%                                           142
  \[[@B36-nutrients-10-00555]\]   4%            21.1%                                           171
  \[[@B39-nutrients-10-00555]\]                 29.1%        42.40%                             420
  \[[@B41-nutrients-10-00555]\]   10%                                                           73
  \[[@B42-nutrients-10-00555]\]   6.4%          11.8%        19.4%                              110
  \[[@B43-nutrients-10-00555]\]                                                   48%           129
  \[[@B45-nutrients-10-00555]\]                              27%                                857
  \[[@B46-nutrients-10-00555]\]                 12.8%                                           86
  \[[@B48-nutrients-10-00555]\]   1.7%          17.9%                                           57
  \[[@B49-nutrients-10-00555]\]   11.6%         20.6%                                           302
                                                **23,093**                                      
  Total mortality (%)             7.4%          20.4%        29.3%    39.4%       48%           

nutrients-10-00555-t006_Table 6

###### 

Nutritional intervention in patients with hip fracture.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author\                                            Design\                                                                                                    *n* (Male/Female)\        BMI kg/m^2^ (Mean ± SD)\          Exclusion Criteria                                                                                                                                                                                                               Results
  Year\                                              Aim                                                                                                        Age, Mean ± SD (years)\   Measurement of Body Composition                                                                                                                                                                                                                                    
  Origin                                                                                                                                                        Follow-Up (FU)                                                                                                                                                                                                                                                                               
  -------------------------------------------------- ---------------------------------------------------------------------------------------------------------- ------------------------- --------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Schürch \[[@B50-nutrients-10-00555]\]\             RCT\                                                                                                       *n* 82 (8/74)\            24.3 ± 4.0 kg/m^2^\               Pathologic fracture, fracture caused by severe trauma, history of contralateral hip fracture, severe mental impairment, bone disease, renal failure, and life expectancy \< 1 year                                               IG (at 6m):\
  1998\                                              Effects of oral protein supplements on bone metabolism                                                     IG 41\                    MAC (cm)\                                                                                                                                                                                                                                                          ↓ rehabilitation stay (42.2 ± 6.6 vs. 53 ± 4.6 days) *p* = 0.018\
  Switzerland                                                                                                                                                   CG 41\                    24.1 ± 3.1                                                                                                                                                                                                                                                         ↑increase IGF-1 and IgM *p* \< 0.05\
                                                                                                                                                                80.7 ± 7.4 years\                                                                                                                                                                                                                                                                            50% reduction of proximal femur bone loss (1 year)
                                                                                                                                                                6 months                                                                                                                                                                                                                                                                                     

  Espaulella \[[@B36-nutrients-10-00555]\]\          RCT\                                                                                                       *n* 171 (36/135)\         25.4 ± 5 kg/m^2^\                 Advanced dementia, intravenous nutrition, pathologic fractures, and accidental falls                                                                                                                                             Patients with ≥1 complication (6 months):\
  2000\                                              Nutritional supplement and functional recovery, complications and mortality                                IG 85\                    MAC: 24.6 ± 3.8 cm\                                                                                                                                                                                                                                                IG 44 (55%)\
  Spain                                                                                                                                                         CG 86\                    Albumin: 35 ± 5.5 g/L                                                                                                                                                                                                                                              CG 57 (70.4%) *p* = 0.04\
                                                                                                                                                                82.6 ± 6.6 years\                                                                                                                                                                                                                                                                            IG: ↑ increase albumin (3 months and 6 months)
                                                                                                                                                                Follow-up: 6 months                                                                                                                                                                                                                                                                          

  Bruce \[[@B51-nutrients-10-00555]\]\               RCT\                                                                                                       *n* 109 (0/109)\          22.8 ± 2.6 kg/m^2^\               BMI \< 20 or BMI \> 30 kg/m^2^, residents of nursing homes, diseases that influence nutritional intake, diabetes, and fracture due to a major trauma                                                                             Weight loss (all patients):\
  2003\                                              Nutritional supplements and prevention of weight loss and improvement of outcomes                          IG 50\                    Albumin 38.8 ± 4.1 g/L                                                                                                                                                                                                                                             At 4 weeks\
  Australia                                                                                                                                                     CG 59\                                                                                                                                                                                                                                                                                       31.5% \> 5% weight loss\
                                                                                                                                                                83.9 ± 7.7 years\                                                                                                                                                                                                                                                                            20.7% \> 7.5% weight loss\
                                                                                                                                                                Follow-up: 6 months                                                                                                                                                                                                                                                                          At 8 weeks\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             27.4% \> 5% weight loss\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             14.6% \> 5% weight loss\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             Fewer weight loss ↔ ↑ number of cane (*p* = 0.019) and ↑duration of supplementation (*p* \< 0.05)

  Houwing \[[@B56-nutrients-10-00555]\]\             RCT\                                                                                                       *n* 103 (19/84)\          23.9 ± 0.5 kg/m^2^                Terminal care, metastatic hip fracture, insulin-dependent diabetes, renal disease, hepatic disease, BMI \> 40 kg/m^2^.                                                                                                           55.3% developed pressure ulcers stage I or II.\
  2003\                                              Effect of a high-protein supplement on the development of pressure ulcers                                  81.0 ± 1.1 years                                                                                                                                                                                                                                                                             Incidence of pressure ulcers stage II:\
  The Netherlands                                                                                                                                                                                                                                                                                                                                                                                                                                            supplement 18%, placebo 28%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             57% of patients developed pressure ulcers by the second day

  Sullivan \[[@B48-nutrients-10-00555]\]\            RCT\                                                                                                       *n* 57 (39/19)\           22.1 ± 4.4 kg/m^2^\               Pathological fracture, significant trauma to other organ systems, metastatic cancer, cirrhosis of the liver, and organ failure                                                                                                   IG:\
  2004\                                              Efficacy of enteral nutrition to decrease complications and long-term outcomes                             IG 27\                    BSF: 6.4 ± 3.3 mm\                                                                                                                                                                                                                                                 ↑ intake of total nutrients *p* = 0.012\
  USA                                                                                                                                                           CG 30\                    Albumin: 33.9 ± 4.5 g/L                                                                                                                                                                                                                                            At discharge:\
                                                                                                                                                                79 ± 7.6 years\                                                                                                                                                                                                                                                                              ↑ Albumin: IG 29 ± 5 vs. CG 25 ± 5 g/L *p* = 0.002
                                                                                                                                                                Follow-up: 6 months                                                                                                                                                                                                                                                                          

  Tidermark \[[@B53-nutrients-10-00555]\]\           RCT\                                                                                                       *n* 60 (0/60)\            20.4 ± 2.3 kg/m^2^                \<70 years, BMI \> 24 kg/m^2^, cognitive impairment and institutionalized, dependent to walk, fractures older than 24 h, pathological fractures, rheumatoid arthritis.                                                           Lean body mass decreased in the CG and protein groups, but remained the same in the protein plus nandrolone group.\
  2004\                                              Effects of nutritional treatment on nutritional and functional status                                      82.9 ± 5.4 years\                                                                                                                                                                                                                                                                            ADL declined only in the CG.
  Sweden                                                                                                                                                        Follow-up: 12 months                                                                                                                                                                                                                                                                         

  Eneroth \[[@B16-nutrients-10-00555]\]\             RCT\                                                                                                       *n* 80\                   23.9 ± 3.8 kg/m^2^                Multiple and pathologic fractures, malignant disease, inflammatory joint disease, dementia, depression, acute psychosis, epileptic seizures, insulin-treated diabetes mellitus, heart, kidney, or liver insufficiency            PEM baseline:\
  2005\                                              Effects of nutritional supplements on nutritional status and intake.                                       IG 40 (7/33)\                                                                                                                                                                                                                                                                                CG 33%, IG 38%\
  Sweden                                                                                                                                                        CG 40 (10/30)\                                                                                                                                                                                                                                                                               Fluid intake:\
                                                                                                                                                                81.4 ± 7.6 years                                                                                                                                                                                                                                                                             IG = 1856 ml, CG = 1300ml (*p* \< 0.0001)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             Energy intake during days 1--10:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             IG = 1296 kcal/day CG = 916 kcal/day (*p* = 0.003)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             Difference between actual and needed energy intake:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             IG = −228 kcal/day CG = −783 kcal/day (*p* = 0.0003)

  Duncan \[[@B49-nutrients-10-00555]\]\              RCT\                                                                                                       *n* 302 (0/302)\          NA                                Pathologic fracture                                                                                                                                                                                                              Mortality\
  2006\                                              Effectiveness of dietetic assistants (DAs) to reduce in-hospital and 4 months mortality.                   GT 145\                                                                                                                                                                                                                                                                                      In trauma unit IG 4%, CG 10% (*p* = 0.048)\
  UK                                                                                                                                                            GC 157\                                                                                                                                                                                                                                                                                      At 4 months IG 13%, CG 23% (*p* = 0.036)\
                                                                                                                                                                83.5 years\                                                                                                                                                                                                                                                                                  -Energy intake = IG 1105; CG 756 kcal/day (*p* \< 0.001)-Supplement intake: IG 409; CG123 kcal/day (*p* \< 0.001)-MAC change: IG −0.9; CG −1.3 cm (*p* = 0.002)Weight change: IG −0.35; CG −1 kg (*p* = 0.16)
                                                                                                                                                                Follow-up: 4 months                                                                                                                                                                                                                                                                          

  Hommel \[[@B39-nutrients-10-00555]\]\              Quasi-experimental\                                                                                        *n* 420\                  24.3 ± 4.4 kg/m^2^\               NA                                                                                                                                                                                                                               Length of hospital stay: IG 11.8 ± 7.4 vs. CG 10.8 ± 5.8 days\
  2007\                                              Effects of an improved care intervention in relation to nutritional status and pressure ulcers             IG 210 (70/140)\          MAC 27.7 ± 4.4 cm\                                                                                                                                                                                                                                                 Pressure ulcers: IG 10%; CG 20.5% (*p* = 0.009)
  Sweden                                                                                                                                                        CG 210 (62/148)\          TSF 14.8 ± 6.8 mm                                                                                                                                                                                                                                                  
                                                                                                                                                                81 ± 10.4 years                                                                                                                                                                                                                                                                              

  Botella-Carretero \[[@B24-nutrients-10-00555]\]\   RCT\                                                                                                       *n* 60 (16/44)\           24.4 ± 3.1 kg/m^2^\               Weight loss \> 5% in 1 month or weight loss \> 10% in 6 months, albumin \< 27 g/L, renal failure, hepatic insufficiency, respiratory failure, and any gastrointestinal condition, any nutritional support in the past 6 months   CG: decrease and worse recovery of albumin and prealbumin (*p* = 0.002; *p* = 0.001)\
  2010\                                              Effect of perioperative supplements on nutritional status and postop complications                         IG 30 (6/24)\             TSF 11.9 ± 4.1 mm\                                                                                                                                                                                                                                                 IG: ↑ energy and protein intake (*p* = 0.042; *p* \< 0.001)\
  Spain                                                                                                                                                         CG 30 (10/20)\            MAC 24.4 ± 3.2 cm\                                                                                                                                                                                                                                                 ↑ protein intake → ↓ post-operative complications OR = 0.925 (0.869--0.985) (*p* = 0.003)
                                                                                                                                                                83.6 ± 5.8 years          MNA 18.6 ± 3.4\                                                                                                                                                                                                                                                    
                                                                                                                                                                                          Albumin 33 ± 4g/L                                                                                                                                                                                                                                                  

  Fabian \[[@B23-nutrients-10-00555]\]\              RCT\                                                                                                       *n* 23 (0/23)\            21.2 ± 3.4 kg/m^2^\               Renal disease, liver failure, severe congestive heart failure, severe pulmonary disease, and any gastrointestinal condition that might preclude the patient from adequate oral nutritional intake                                IG ↑ energy and protein intake (*p* \< 0.05)\
  2011\                                              Effect of nutritional supplement on post-operative oxidative stress and length of hospital stay            IG 14\                    Albumin 36.6 ± 3.8 g/L                                                                                                                                                                                                                                             Albumin, total protein, and total antioxidant capacity (post-operative):\
  Austria                                                                                                                                                       CG 9\                                                                                                                                                                                                                                                                                        ↓ CG (*p* \< 0.05) ↓ IG\
                                                                                                                                                                83.8 ± 7.4 years\                                                                                                                                                                                                                                                                            Advance oxidation protein products and malondialdehyde: in CG levels still elevated during time but not in IG\
                                                                                                                                                                Follow-up: 3 weeks                                                                                                                                                                                                                                                                           Length of hospital stay: IG 17 ± 4 vs. CG 19 ± 9 days\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             Albumin ↔ CRP and total antioxidant capacity (*p* \< 0.05)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             Length of hospital stay ↔ AOPP and MDA (*p* \< 0.01)

  Hoekstra \[[@B25-nutrients-10-00555]\]\            Prospective\                                                                                               *n* 127 (31/96)\          26.8 ± 4.5 kg/m^2^                Severe dementia, cancer, pathologic fracture, renal and hepatic dysfunction, pacemaker                                                                                                                                           IG ↑ energy intake protein, vitamin D, zinc, calcium (*p* \< 0.01)\
  2011\                                              Effectiveness of a multidisciplinary intervention on nutritional status                                    IG 61\                                                                                                                                                                                                                                                                                       IG lower reduction of EuroQol-5D (*p* \< 0.05)\
  The Netherlands                                                                                                                                               CG 66\                                                                                                                                                                                                                                                                                       ↓\* BMI, BCM, and FM (3 months) (both groups)
                                                                                                                                                                80.3 ± 8.3 years                                                                                                                                                                                                                                                                             

  Li \[[@B28-nutrients-10-00555]\]\                  Randomized (1 year)\                                                                                       *n* 162 (51/111)\         NA                                Cognitive impairment, terminally ill                                                                                                                                                                                             Malnutrition prevalence: IG 60% vs. CG 67%\
  2013\                                              Effects of protein-energy malnutrition on the functional recovery                                          IG 80\                                                                                                                                                                                                                                                                                       MN → ↓ performance of ADL, IADL, and recovery of walking ability (*p* \< 0.05)\
  Taiwan                                                                                                                                                        CG 82\                                                                                                                                                                                                                                                                                       IG → ↑ performance of ADL, IADL, and recovery of walking ability (*p* \< 0.01)
                                                                                                                                                                78.2 years                                                                                                                                                                                                                                                                                   

  Wyers \[[@B29-nutrients-10-00555]\]\               RCT\                                                                                                       *n* 152 (108/44)\         NA                                Pathological or periprosthetic fracture, disease of bone metabolism, life expectancy \< 1 year, ONS before hospital admission, dementia.                                                                                         The additional cost of the nutritional intervention was only 3% of the total cost\
  2013\                                              Cost-effectiveness of dietary intervention comprising combined dietetic counseling and ONS                 IG 73\                                                                                                                                                                                                                                                                                       Total cost was not significantly different between both groups\
  The Netherlands                                                                                                                                               CG 79\                                                                                                                                                                                                                                                                                       Nutritional intervention was likely to be cost effective for weight as the outcome over 3 months
                                                                                                                                                                78.5 years                                                                                                                                                                                                                                                                                   

  Myint \[[@B52-nutrients-10-00555]\]\               RCT\                                                                                                       *n* 121 (41/80)\          20.7 ± 2.9 kg/m^2^\               Tube feeding, unstable medical condition, BMI ≥ 25 kg/m^2^, malignancy, contraindication for high-protein diet, and mentally incapacitated                                                                                       BMI decrease of 0.25 and 0.003 kg/m^2^ in the ONS group, and 0.72 and 0.49 kg/m^2^ at hospital and follow-up (*p* = 0.012)\
  2013\                                              Clinical, nutritional and rehabilitation effects of an oral nutritional supplementation                    IG 61\                    TSF 12.6 ± 5.6 mm\                                                                                                                                                                                                                                                 Length of hospital stay was shortened by 3.8 days in the ONS group (*p* = 0.04)\
  Hong Kong                                                                                                                                                     CG 60\                    MAC 24.3 ± 3 cm\                                                                                                                                                                                                                                                   Intake adequate: 67% in the ONS group, 9% in the control group (*p* \< 0.001)
                                                                                                                                                                81.3 ± 6.5 years\         Albumin 29.3 ± 4.6 g/L                                                                                                                                                                                                                                             
                                                                                                                                                                Follow-up: 6 months                                                                                                                                                                                                                                                                          

  Anbar \[[@B17-nutrients-10-00555]\]\               RCT\                                                                                                       *n* 50 (17/33)\           24.9 ± 3.9 kg/m^2^                Presented to hospital \>48 h after the injury, steroids and/or immunosuppression therapy, oncologic disease, multiple fractures, dementia                                                                                        ONS = 19.6% of total energy\
  2014\                                              Optimization of supplementation by measurement of resting energy requirements and the effect on outcomes   IG 22\                                                                                                                                                                                                                                                                                       IG:\
  Israel                                                                                                                                                        CG 28\                                                                                                                                                                                                                                                                                       ↑ Energy and protein intake (*p* = 0.001)\
                                                                                                                                                                83.1 ± 6.3 years                                                                                                                                                                                                                                                                             ↓ complications (*p* = 0.012) and infections (*p* = 0.008)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             ↓ length of hospital stay (*p* = 0.061)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             In all patients:\
                                                                                                                                                                                                                                                                                                                                                                                                                                                             Energy balance ↔ complications (r = −0.417; *p* = 0.003) and with length of hospital stay (r = −0.282; *p* = 0.049)

  Ekinci \[[@B55-nutrients-10-00555]\]\              RCT\                                                                                                       *n* 62 (0/62)\            22.0 ± 2.4 kg/m^2^                Diabetes, renal and hepatic failure, gastrointestinal intolerance, endocrine pathology, and dementia.                                                                                                                            Patients who were mobile on day 30:\
  2016\                                              Effects of CaHMB on wound healing, mobilization, fat-free mass and muscle strength                         IG 32\                                                                                                                                                                                                                                                                                       - IG 81.3% vs. CG 26.7% (*p* = 0.001)\
  Turkey                                                                                                                                                        CG 30\                                                                                                                                                                                                                                                                                       Muscle strength on day 30 was higher in IG vs. CG (*p* = 0.026)
                                                                                                                                                                82.6 ± 7.1 years                                                                                                                                                                                                                                                                             

  Malafarina \[[@B54-nutrients-10-00555]\]\          RCT\                                                                                                       *n* 107\                  25.4 ± 4.9 kg/m^2^\               Diabetes, Barthel index \<40 prior to the fracture, tumor, pathological or high-impact fractures                                                                                                                                 BMI and ALM was stable in IG, but decreased in CG.\
  2017\                                              Effects of ONS on muscle mass and nutritional biomarkers                                                   IG 55\                    Albumin 3.1 ± 0.4 g/dL                                                                                                                                                                                                                                             ONS (*p* = 0.006), function ambulation categories prior to the fracture (*p* = 0.007) and Barthel index prior to the fracture (*p* = 0.007) are protective for loss of ALM
  Spain                                                                                                                                                         CG 52\                                                                                                                                                                                                                                                                                       
                                                                                                                                                                85.4 ± 6.3 years                                                                                                                                                                                                                                                                             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ALM = appendicular lean mass; AOPP: advanced oxidation protein products; BCM: Body Cellular Mass; BMI = body mass index; BSF = biceps skinfold thickness; CG = control group; FM: fatt mass; IADL: instrumental activities o daily living; IGF-1 = insulin-like growth factor; HS = handgrip strength; IG = intervention group; MAC = mid-arm circumference; MNA = Mini Nutritional Assessment; ONS = oral nutritional supplement; RCT = randomized controlled trial; TSF = triceps skin fold thickness; ↓\* = significantly less; ↑\* = significantly more; ↔ = significant association.
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###### 

Characteristics of the nutritional intervention and composition of the nutritional supplementation used in the included studies.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author\                                            Type of Supplement\                                                                                                       kcal                                                                                                      Nutritional Composition                                                  Treatment Duration\                                                                                                              Control Group
  Year\                                              Administration Method                                                                                                                                                                                                                                                                                        Adherence Rate (%)                                                                                                               
  Origin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  -------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------
  Schürch \[[@B50-nutrients-10-00555]\]\             Oral liquid supplement; single oral dose of vit D~3~ 200.000 UI\                                                          250 kcal/day                                                                                              20 g protein, 3.1 g lipid, 35.7 g carbohydrates,\                        5 days a week for 6 months\                                                                                                      Placebo: 54.5 g carbohydrates\
  1998\                                              Ca: 550 mg/day                                                                                                                                                                                                                      90% milk proteins                                                        AR:\                                                                                                                             Single oral dose of vitamin D 200.000 UI\
  Switzerland                                                                                                                                                                                                                                                                                                                                                     IG 73%\                                                                                                                          Calcium: 550 mg/day
                                                                                                                                                                                                                                                                                                                                                                  CG 80%                                                                                                                           

  Espaulella \[[@B36-nutrients-10-00555]\]\          Oral liquid supplement\                                                                                                   149 kcal                                                                                                  20 g protein, 800 mg calcium, 25 IU vitamin D3                           60 days\                                                                                                                         Placebo 200 mL, 155 kcal; mainly carbohydrates
  2000\                                              200 mL                                                                                                                                                                                                                                                                                                       AR:\                                                                                                                             
  Spain                                                                                                                                                                                                                                                                                                                                                           IG 94.1%\                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                  CG 94.2%                                                                                                                         

  Bruce \[[@B51-nutrients-10-00555]\]\               Oral liquid supplement (235 mL/day)                                                                                       352 kcal                                                                                                  17.6 g protein, 11.8 g fat, 44.2 g carbohydrate, vitamins and minerals   28 days after surgery                                                                                                            Hospital diet only
  2003\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Australia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Houwing \[[@B56-nutrients-10-00555]\]\             Oral liquid supplement (400 mL/day)                                                                                       500 kcal                                                                                                  40 g protein                                                             Immediately postoperatively during 4 weeks or until discharge\                                                                   Non-caloric placebo supplement
  2003\                                                                                                                                                                                                                                                                                                                                                           AR: 75% of patients consumed \>75% of daily dose                                                                                 
  The Netherlands                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Sullivan \[[@B48-nutrients-10-00555]\]\            Standard care + post-operative nightly via enteral feeding tube:\                                                         1031 kcal                                                                                                 85.8 g protein                                                           When volitional intake exceeded 90% of estimated requirements for 3 consecutive days or was discharged: mean 15.8 ± 16.4 days\   Standard care
  2004\                                              1375 mL (125 mL/h) over 11 h                                                                                                                                                                                                                                                                                 AR: 83.3%                                                                                                                        
  USA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Tidermark \[[@B53-nutrients-10-00555]\]\           PR: protein-rich liquid supplement (200 mL/day)\                                                                          200 kcal/day\                                                                                             20 g protein                                                             6 months                                                                                                                         Standard treatment\
  2004\                                              PR-N: PR + nandrolone decanoate injections (every third week)\                                                            nandrolone: 25 mg intramuscular injection                                                                                                                                                                                                                                                                           1 g of calcium + 400 IE vitamin D3
  Sweden                                             1 g of calcium + 400 IE vitamin D3                                                                                                                                                                                                                                                                                                                                                                                                            

  Eneroth \[[@B16-nutrients-10-00555]\]\             Hospital diet + intravenous nutrition (1 l/day) followed by\                                                              Oral supplement 400 kcal/day                                                                              IV: amino acids, fat, carbohydrate, and electrolytes                     3 days → IV\                                                                                                                     Hospital diet only
  2005\                                              400 mL/day oral supplement                                                                                                                                                                                                                                                                                   7 days → oral                                                                                                                    
  Sweden                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Duncan \[[@B49-nutrients-10-00555]\]\              NA                                                                                                                        Mean supplement: 409 kcal/day                                                                             NA                                                                       NA                                                                                                                               Mean standard supplement: 123 kcal/day
  2006\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  UK                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Hommel \[[@B39-nutrients-10-00555]\]\              Oral nutritional supplement twice a day                                                                                   125 kcal/100 mL enriched with arginine, zinc, vitamins A, B, C, and E, selenium, and carotenoids          NA                                                                       From post-surgery to discharge                                                                                                   NA
  2007\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Sweden                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Botella-Carretero \[[@B24-nutrients-10-00555]\]\   Oral nutritional supplement intake (2 × 200 mL/day)                                                                       400 kcal/day                                                                                              40 g protein/day                                                         From admission until discharge\                                                                                                  Control group: no supplement
  2010\                                                                                                                                                                                                                                                                                                                                                           AR 52.2 ± 12.1%                                                                                                                  
  Spain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Fabian \[[@B23-nutrients-10-00555]\]\              Oral liquid supplement                                                                                                    Supplements were administered when intake of energy \< 20 kcal and/or protein \< 1 g/kg body weight/day   40% protein, 41% carbohydrate, 19% fat, vitamins and minerals            From post-surgery to discharge                                                                                                   Standard medical treatment
  2011\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Austria                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Hoekstra \[[@B25-nutrients-10-00555]\]\            Nurse and doctor encouraged and motivated patients to eat and drink; if MNA \< 24, dietician consulted with the patient   NA                                                                                                        NA                                                                       NA                                                                                                                               Standard nutritional care
  2011\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  The Netherlands                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Wyers \[[@B29-nutrients-10-00555]\]\               Oral liquid nutritional supplement (500 mL/day)\                                                                          500 kcal                                                                                                  40 g protein                                                             Started during hospital admission and continued until 3 months after surgery                                                     Usual care\
  2013\                                              Dietetic counseling                                                                                                                                                                                                                                                                                                                                                                                                                           ONS on demand: 13% received ONS and 23% received dietetic counseling
  The Netherlands                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Myint \[[@B52-nutrients-10-00555]\]\               Oral liquid nutritional supplement (240 mL twice daily)\                                                                  500 kcal                                                                                                  18--24 g protein                                                         Started within 3 days after admission until discharge or 28 days\                                                                NA\
  2013\                                              1.2 g of calcium + 800--1000 IU vitamin D                                                                                                                                                                                                                                                                    AR = 77.7%                                                                                                                       1.2 g of calcium + 800--1000 IU vitamin D
  Hong Kong                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Anbar \[[@B17-nutrients-10-00555]\]\               Standard ONS (237 mL) or\                                                                                                 355 kcal\                                                                                                 13.5 g protein\                                                          Started 24 h after surgery\                                                                                                      Usual hospital diet = 1800 kcal, 80 g protein
  2014\                                              diabetic ONS (237 mL)\                                                                                                    237 kcal                                                                                                  9.9 g protein                                                            AR = 100%                                                                                                                        
  Israel                                             Patients received the difference between intake and measured energy expenditure                                                                                                                                                                                                                                                                                                                                                               

  Ekinci \[[@B55-nutrients-10-00555]\]\              Oral liquid nutritional supplement (220 mL twice daily)                                                                   NA                                                                                                        36 g protein\                                                            30 days                                                                                                                          Usual hospital diet: 1900 kcal, 76 g protein, 63 g fat
  2016Turkey                                                                                                                                                                                                                                                                             3 g CaHMB\                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                         1000 IU vitamin D                                                                                                                                                                                         

  Malafarina \[[@B54-nutrients-10-00555]\]\          Oral liquid nutritional supplement (220 mL twice daily)                                                                   660 kcal                                                                                                  60 g protein\                                                            During hospital admission, until discharge\                                                                                      Usual hospital diet: 1500 kcal, 87 g protein, 59 g fat
  2017\                                                                                                                                                                                                                                                                                  4.6 g CaHMB\                                                             Mean treatment duration: 42.3 ± 20.9 days\                                                                                       
  Spain                                                                                                                                                                                                                                                                                  1500 IU vitamin D                                                        AR = all of the subjects took more than 80%                                                                                      
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
